title: Advances in the pharmacologic treatment of tension-type headache.
abstract: Tension-type headache (TTH) is the most prevalent form of primary headache in the general population. We discuss advances in the treatment of TTH. We briefly review nonpharmacologic therapies and then focus on current pharmacologic strategies. For acute treatment, the most common interventions involve the use of simple analgesics and anti-inflammatory medications, often taken by the patient without a prescription. For preventive treatment, amitriptyline is the best-studied drug, but nortriptyline, mirtazapine, tizanidine, the selective serotonin reuptake inhibitors, and other medications can be used. We close by discussing potential future therapies, including calcitonin gene-related peptide receptor antagonism, as well as substance P and the nitric oxide pathways.
authors.affiliation: Global Director for Scientific Affairs, Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. marcelo_bigal@merck.com
authors.forename: Marcelo E
authors.initials: ME
authors.lastname: Bigal
authors.forename: Alan M
authors.initials: AM
authors.lastname: Rapoport
authors.forename: Richard
authors.initials: R
authors.lastname: Hargreaves
mesh_terms: D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*; D018781:Tension-Type Headache / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D004364:Pharmaceutical Preparations